Please login to the form below

Not currently logged in
Email:
Password:

Endocyte appoints Parexel's Scot Harper to oversee clinical trials

He also previously served at Novartis and Lilly

Scot Harper, Endocyte Endocyte has appointed Dr Scot Harper as VP, clinical operations, where he will be responsible for clinical trial operations at the US biopharma company.

Dr Harper (pictured right) joins from clinical research organisation (CRO) Parexel, where he held the role of global portfolio director for oncology, overseeing clinical activities for cancer drugs from phase I to IV development.

He also has experience working in clinical operations for major pharma companies, serving as VP of Novartis' North American clinical operations, and senior director of clinical operations at Lilly.

Prior to this, Dr Harper worked in new product development at SmithKline Beechham.

Endocyte, which focuses on developing therapies for the treatment of cancer and other serious diseases, will benefit from his experience of working on the development of major oncology brands like Tasigna and Gleevec.

“Scot has deep expertise in the drug development process and management of all stages of clinical trials, and he will play a key role at Endocyte as we seek to expand and advance our platform,” said Ron Ellis, Endocyte's president and CEO, referencing the development of oncology candidates vintafolide and etarfolatide, which are in phase III and phase II trials respectively.

In addition, Endocyte says it has three new drug candidates scheduled to enter the clinic before the end of 2014.

9th May 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics